The clinical diagnostic accuracy of CBS is poor due to the overlapping clinical features with other neurodegenerative disorders such as Alzheimer’s disease (AD), progressive supranuclear pPalsy (PSP) and tau-positive forms of frontotemporal dementia (FTD). This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.